| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 35 | 2020 | The (generalized) hydrogen rule for organic molecules | CLAESEN, Jurgen; VALKENBORG, Dirk; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 36 | 2020 | A “Refined Hydrogen Rule” and a “Refined Hydrogen and Halogen Rule” for Organic Molecules | CLAESEN, Jurgen; VALKENBORG, Dirk; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 37 | 2019 | Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis | Saad, Everardo D.; Squifflet, Pierre; BURZYKOWSKI, Tomasz; Quinaux, Emmanuel; Delaloge, Suzette; Mavroudis, Dimitris; Perez, Edith; Piccart-Gebhart, Martine; Schneider, Bryan P.; Slamon, Dennis; Wolmark, Norman; BUYSE, Marc | Journal Contribution | A1 |
| 38 | 2019 | The impact of the method of extracting metabolic signal from H-1-NMR data on the classification of samples: A case study of binning and BATMAN in lung cancer | PADAYACHEE, Trishanta; KHAMIAKOVA, Tatsiana; LOUIS, Evelyne; ADRIAENSENS, Peter; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 39 | 2019 | Detection of atypical data in multicenter clinical trials using unsupervised statistical monitoring | Trotta, Laura; Kabeya, Yuusuke; BUYSE, Marc; Doffagne, Erik; Venet, David; Desmet, Lieven; BURZYKOWSKI, Tomasz; Tsuburaya, Akira; Yoshida, Kazuhiro; Miyashita, Yumi; Morita, Satoshi; Sakamoto, Junichi; Praveen, Paurush; Oba, Koji | Journal Contribution | A1 |
| 40 | 2019 | A Poisson approach to the validation of failure time surrogate endpoints in individual patient data meta-analyses | Rotolo, Federico; PAOLETTI, Xavier; BURZYKOWSKI, Tomasz; BUYSE, Marc; Michiels, Stefan | Journal Contribution | A1 |
| 41 | 2019 | Joint modelling of a binary and a continuous outcome measured at two cycles to determine the optimal dose | Ezzalfani, Monia; BURZYKOWSKI, Tomasz; PAOLETTI, Xavier | Journal Contribution | A1 |
| 42 | 2019 | Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer | BURZYKOWSKI, Tomasz; Coart, E.; Saad, E.D.; Shi, Q.; Sommeijer, D.W.; Bokemeyer, C.; Díaz-Rubio, E.; Douillard, Jean-Yves; Falcone, A.; Fuchs, C.; Goldberg, R.M.; Hecht, R.; Hoff, P.M.; Hurwitz, H.; Kabbinavar, F.F.; Koopman, M.; Maughan, T.; Punt, C.J.A.; Saltz, L.; Schmoll, Hans-Joachim; Seymour, M.T.; Tebbutt, N.C.; Tournigand, C.; Van Cutsem, E.; de Gramont, A.; Zalcberg, J.R.; BUYSE, Marc | Journal Contribution | A1 |
| 43 | 2019 | The retrospective study of 93 patients with transmigration of mandibular canine and a comparative analysis with a control group | Plakwicz, Pawel; Abramczyk, Joanna; Wojtaszek-Lis, Julita; Sajkowska, Jolanta; Warych, Barbara; Gawron, Katarzyna; BURZYKOWSKI, Tomasz; Zadurska, Malgorzata; Czochrowska, Ewa Monika; Wojtowicz, Andrzej; Gorska, Renata; Kukula, Krzysztof | Journal Contribution | A1 |
| 44 | 2019 | Chronological Trends in Progression-Free, Overall, and Post-Progression Survival in First-Line Therapy for Advanced NSCLC | Rutkowski, Jacek; Saad, Everardo D.; BURZYKOWSKI, Tomasz; BUYSE, Marc; Jassem, Jacek | Journal Contribution | A1 |
| 45 | 2019 | A multivariate linear model for investigating the association between gene-module co-expression and a continuous covariate | PADAYACHEE, Trishanta; KHAMIAKOVA, Tatsiana; SHKEDY, Ziv; Salo, Perttu; Perola, Markus; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 46 | 2019 | A Bayesian Framework Allowing Incorporation of Retrospective Information in Prospective Diagnostic Biomarker-Validation Designs | GARCIA BARRADO, Leandro; Coart, Els; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 47 | 2019 | A Multivariate Negative-Binomial Model with Random Effects for Differential Gene-Expression Analysis of Correlated mRNA Sequencing Data | Kazakiewicz, D; CLAESEN, Jurgen; GORCZAK, Katarzyna; Plewczynski, D; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 48 | 2019 | A Conceptual Framework for Abundance Estimation of Genomic Targets in the Presence of Ambiguous Short Sequencing Reads | GORCZAK, Katarzyna; CLAESEN, Jurgen; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 49 | 2019 | De novo prediction of the elemental composition of peptides and proteins based on a single mass | CLAESEN, Jurgen; VALKENBORG, Dirk; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 50 | 2019 | Experimental design in quantitative proteomics | BURZYKOWSKI, Tomasz; CLAESEN, Jurgen; VALKENBORG, Dirk | Book Section | B2 |
| 51 | 2018 | The search for surrogate endpoints for immunotherapy trials | BUYSE, Marc; BURZYKOWSKI, Tomasz; Saad, Everardo D. | Journal Contribution | A2 |
| 52 | 2018 | Comprehensive analysis of cancer stemness | Malta, Tathiane M.; Sokolov, Artem; Gentles, Andrew J.; BURZYKOWSKI, Tomasz; Poisson, Laila; Weinstein, John; Kaminska, Bozena; Huelsken, Joerg; Omberg, Larsson; Gevaert, Olivier; Colaprico, Antonio; Czerwinska, Patrycja; Mazurek, Sylwia; Mishra, Lopa; Heyn, Holger; Krasnitz, Alex; Godwin, Andrew K.; Lazar, Alexander J.; Stuart, Joshua M.; Hoadley, Katherine; Laird, Peter W.; Noushmehr, Houtan; Wiznerowicz, Maciej | Journal Contribution | M |
| 53 | 2018 | Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation | Malta, Tathiane M.; Sokolov, Artem; Gentles, Andrew J.; BURZYKOWSKI, Tomasz; Poisson, Laila; Weinstein, John N.; Kaminska, Bozena; Huelsken, Joerg; Omberg, Larsson; Gevaert, Olivier; Colaprico, Antonio; Czerwinska, Patrycja; Mazurek, Sylwia; Mishra, Lopa; Heyn, Holger; Krasnitz, Alex; Godwin, Andrew K.; Lazar, Alexander J.; Stuart, Joshua M.; Hoadley, Katherine A.; Laird, Peter W.; Noushmehr, Houtan; Wiznerowicz, Maciej | Journal Contribution | A1 |
| 54 | 2018 | Sequential double cross-validation for assessment of added predictive ability in high-dimensional omic applications | Rodriguez-Girondo, Mar; Salo, Perttu; BURZYKOWSKI, Tomasz; Perola, Markus; HOUWING-DUISTERMAAT, Jeanne; Mertens, Bart | Journal Contribution | A1 |
| 55 | 2018 | Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better? | Saad, Everardo D.; Zalcberg, John R.; Peron, Julien; Coart, Elisabeth; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 56 | 2018 | Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated results | Mackiewicz, Jacek; BURZYKOWSKI, Tomasz; Izycki, Dariusz; Mackiewicz, Andrzej | Journal Contribution | A1 |
| 57 | 2018 | Statistical evaluation of surrogate endpoints in cancer clinical trials | BUYSE, Marc; MOLENBERGHS, Geert; PAOLETTI, Xavier; Oba, K.; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz | Book Section | B2 |
| 58 | 2017 | Applied Surrogate Endpoint Evaluation Methods with SAS and R | ALONSO ABAD, Ariel; BIGIRUMURAME, Theophile; BURZYKOWSKI, Tomasz; BUYSE, Marc; MOLENBERGHS, Geert; MUCHENE, Leacky; PERUALILA, Nolen Joy; SHKEDY, Ziv; VAN DER ELST, Wim | Book | B1 |
| 59 | 2017 | Evaluation of failure time surrogate endpoints in individual patient data meta-analyses of randomized clinical trials. A poisson approach | Rotolo, Federico; PAOLETTI, Xavier; BURZYKOWSKI, Tomasz; BUYSE, Marc; Michiels, Stefan | Journal Contribution | M |
| 60 | 2017 | Adoption of Pathologic Complete Response as a Surrogate End Point in Neoadjuvant Trials in HER2-Positive Breast Cancer Still an Open Question | BURZYKOWSKI, Tomasz; Saad, Everardo D.; BUYSE, Marc | Journal Contribution | A1 |
| 61 | 2017 | Precision medicine needs randomized clinical trials | Saad, Everardo D.; PAOLETTI, Xavier; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 62 | 2017 | Use of the Beta-Binomial Model for Central Statistical Monitoring of Multicenter Clinical Trials | Desmet, Lieven; Venet, David; Doffagne, Erik; Timmermans, Catherine; LEGRAND, Catherine; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 63 | 2017 | Estimation of diagnostic accuracy of a combination of continuous biomarkers allowing for conditional dependence between the biomarkers and the imperfect reference-test | GARCIA BARRADO, Leandro; Coart, Els; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 64 | 2017 | An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number | Szutowicz-Zielinska, Ewa; Konopa, Krzysztof; Kowalczyk, Anna; Suszko-Kazarnowicz, Malgorzata; Duchnowska, Renata; Szczesna, Aleksandra; Ratajska, Magdalena; Sowa, Aleksander; Limon, Janusz; Biernat, Wojciech; BURZYKOWSKI, Tomasz; Jassem, Jacek; Dziadziuszko, Rafal | Journal Contribution | A1 |
| 65 | 2017 | The Analysis of Peptide-Centric Mass-Spectrometry Data Utilizing Information About the Expected Isotope Distribution | BURZYKOWSKI, Tomasz; CLAESEN, Jurgen; VALKENBORG, Dirk | Book Section | B2 |
| 66 | 2016 | Statistical monitoring of data quality and consistency in the Stomach Cancer Adjuvant Multi-institutional Trial Group Trial | Timmermans, Catherine; Doffagne, Erik; Venet, David; Desmet, Lieven; LEGRAND, Catherine; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 67 | 2016 | Statistical evaluation of surrogate endpoints with examples from cancer clinical trials | BUYSE, Marc; MOLENBERGHS, Geert; PAOLETTI, Xavier; Oba, Koji; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 68 | 2016 | Neoadjuvant as Future for Drug Development in Breast Cancer-Letter | BUYSE, Marc; BURZYKOWSKI, Tomasz; Saad, Everardo D. | Journal Contribution | A1 |